CHST3 and osteoarthritis: Finally, the carbohydrate sulfotransferase 3 agonist thalidomide has been shown to attenuate early osteoarthritis development in a mouse medial meniscus destabilization model through a mechanism involving the downregulation of vascular endothelial growth factor (VEGF) expression (Seegmiller et al., 2019).